ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
William L. Holman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holman, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holman, W. L.
Related Collections
Right arrow Mechanical Circulatory Assistance

Ann Thorac Surg 2005;80:948-949
© 2005 The Society of Thoracic Surgeons

Original article: Cardiovascular

Invited commentary

William L. Holman, MD

Department of Surgery, University of Alabama at Birmingham, 1530 3rd Ave S, ZRB 719, Birmingham, AL 35294-0007

(Email: wholman@its.uab.edu).

The first 20% of the full text of this article appears below.

This study [1] is a nicely performed, non-randomized prospective analysis of anti-leukocyte antigen (HLA) antibodies measured in patients receiving DeBakey/MicroMed left ventricular assist devices (VADs) (MicroMed Technology, Inc, Houston, TX) as a bridge to heart transplantation. No patients had IgG antibodies develop to class I or II antigens. Retrospective cross matches were negative and the prevalence of acute rejection was 6% in the first 6 months and 4.3% in the second 6 months after . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.